在血中使用组织类型的血原激活剂诱导的血凝块溶解时间评估血中血摩杜林/血可激活的纤维溶解抑制剂的功能

Tetsumei Urano1,2, Yoshie Sano1, Yuji Suzuki3

  • 1Department of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

概括

可溶性血栓模块素 (sTM) /TAFI轴调节纤维解质. 再组合的sTM (rsTM) 激活TAFI,抑制凝块溶解,在血中足够的痕量sTM.

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
668